Olivera, Pablo
Danese, Silvio
Jay, Nicolas
Natoli, Gioacchino
Peyrin-Biroulet, Laurent
Article History
First Online: 18 January 2019
Competing interests
: P.O. has received financial support for research from Abbvie, Ferring and Takeda and lecture and consulting fees from Abbvie and Takeda. S.D. has received speaking, consultancy or advisory board member fees from Abbvie, Allergan, Biogen, Boehringer-Ingelheim, Celgene, Celltrion, Ferring, Hospira, Johnson and Johnson, Merck, MSD, Mundipharma, Pfizer, Sandoz, Takeda, TiGenix, UCB Pharma and Vifor. L.P.-B. has received consulting fees from Abbvie, Amgen, Biogaran, Boehringer-Ingelheim, Bristol-Myers Squibb, Celltrion, Ferring, Genentech, HAC Pharma, Hospira, Index Pharmaceuticals, Janssen, Lilly, Merck, Mitsubishi, Norgine, Pfizer, Pharmacosmos, Pilege, Sandoz, Takeda, Therakos, Tillotts, UCB Pharma and Vifor and lecture fees from Abbvie, Ferring, HAC Pharma, Janssen, Merck, Mitsubishi, Norgine, Takeda, Therakos, Tillotts and Vifor. N.J. and G.N. declare no competing interests.
Free to read: This content has been made available to all.